| Patient | Susan B. Anthony |
|---|---|
| Date of birth | 1820-02-15 |
| Identifiers | MRN HR-NI014-SYN-TD; SSN (made up) 000-14-7302 |
| Document date | 2026-11-01 |
| Author | Harold Pemberton, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for breathlessness on exertion and ankle swelling. Concerns: Breathlessness and ankle swelling after travel threaten her lecture schedule; Does not want to be kept in bed or slowed down by treatment. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Furosemide 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1905-03-16 to 1905-06-29 | completed | S |
| Furosemide 20 mg oral tablet, one tablet by mouth as needed for a weight gain of more than 1 kg in a day or 2 kg in a week | One tablet by mouth once daily as needed for weight gain | Oral route | 1905-06-29 | active | S |
| Empagliflozin 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1905-03-16 | active | S |
| Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) by mouth daily | One-half tablet by mouth daily | Oral route | 1905-03-30 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| 12-lead electrocardiogram: sinus rhythm, left ventricular hypertrophy by voltage, no atrial fibrillation | 1905-03-16 to 1905-03-16 | completed | S |
| Transthoracic echocardiography: ejection fraction 62 percent, concentric remodeling with septal thickness 11 mm, enlarged left atrium, raised filling pressures, no significant valve disease | 1905-03-30 to 1905-03-30 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1904-10-06 | High-dose influenza vaccine, 1904-1905 season | completed | S |
| 1905-03-30 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1905-03-30 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1901-11-14 | Recombinant zoster vaccine, two-dose series completed | completed | S |
| 1899-05-11 | Tdap vaccine | completed | S |
| 1905-10-19 | High-dose influenza vaccine, 1905-1906 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| January 1891 | Prolonged la grippe with collapse; pneumonia threatened and she kept to her room for a week | D (CLM-0005) |
| July 26, 1895 | Fainted while speaking at Lakeside, Ohio, followed by a month in bed with what was called nervous prostration; no cardiac evaluation recorded | D (CLM-0006) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died November 25, 1862, at 69, after a sudden two-week illness then called acute neuralgia of the stomach | D (CLM-0003) | |
| mother | Died at 86; cause not recorded in the cited source | D (CLM-0004) | |
| paternal grandfather | Lived past 97; cause of death not recorded in the cited source | D (CLM-0004) | |
| maternal grandmother | Died in her eighty-fourth year; cause not recorded in the cited source | D (CLM-0004) | |
| maternal grandfather | Died in his eighty-fourth year; cause not recorded in the cited source | D (CLM-0004) |
| Concern | Status | Evidence |
|---|---|---|
| Breathlessness and ankle swelling after travel threaten her lecture schedule | active | S |
| Does not want to be kept in bed or slowed down by treatment | active | S |
Most recent measures: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 720 on 1905-06-29; Sodium [Moles/volume] in Serum or Plasma 138 on 1905-09-28; Potassium [Moles/volume] in Serum or Plasma 4.6 on 1905-09-28; Creatinine [Mass/volume] in Serum or Plasma 0.9 on 1905-09-28; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M 63 on 1905-09-28; Glucose [Mass/volume] in Serum or Plasma 93 on 1905-09-28; Magnesium [Mass/volume] in Serum or Plasma 2 on 1905-06-29; Hemoglobin [Mass/volume] in Blood 12.4 on 1905-03-16; Ferritin [Mass/volume] in Serum or Plasma 140 on 1905-03-16; Iron saturation [Mass Fraction] in Serum or Plasma 24 on 1905-03-16; Thyrotropin [Units/volume] in Serum or Plasma 2.4 on 1905-03-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1905-03-16; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 96 on 1905-03-16; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 on 1905-03-16; Overall summary score [KCCQ-12] 76 on 1905-09-28; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1905-10-19; Left ventricular Ejection fraction 62 on 1905-03-30; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 42 on 1905-03-30; Heart valve E velocity/Annulus E wave by US 16 on 1905-03-30; Total score [Mini-Cog] 5 on 1905-10-19; Total score [AUDIT-C] 0 on 1905-10-19 [S]
Strengths and supports: Supports: sister, nieces, and a close circle of younger colleagues [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Heart failure with preserved ejection fraction, NYHA class II to III at diagnosis; synthetic modern diagnosis linked to the documented 1785 heart failure | active | confirmed | I50.32 | S — Synthetic diagnosis confirmed by echocardiogram in the modern episode; the 1906 cause of death remains D. |
| Hypertensive heart disease with heart failure | active | confirmed | I11.0 | S — Synthetic diagnosis; no blood pressure from her lifetime is recorded in the cited sources. |
| Acute viral bronchitis after a head cold, resolved without antibiotics | resolved | confirmed | J20.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1905-03-16 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 1650 | pg/mL | <=125 pg/mL | High | S |
| 1905-03-16 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1905-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1905-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1905-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 64 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1905-03-16 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1905-03-16 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1905-03-16 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1905-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 140 | ng/mL | 30-400 ng/mL | Normal | S |
| 1905-03-16 | Iron saturation [Mass Fraction] in Serum or Plasma | 24 | % | 20-50% | Normal | S |
| 1905-03-16 | Thyrotropin [Units/volume] in Serum or Plasma | 2.4 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1905-03-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1905-03-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 96 | mg/dL | <=99 mg/dL | Normal | S |
| 1905-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 1905-03-16 | Overall summary score [KCCQ-12] | 52 | {score} | S | ||
| 1905-03-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1905-03-30 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1905-03-30 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1905-03-30 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1905-03-30 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 58 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1905-03-30 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1905-03-30 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1905-03-30 | Left ventricular Ejection fraction | 62 | % | 50-70% | Normal | S |
| 1905-03-30 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 42 | mL/m2 | <=34 mL/m² | High | S |
| 1905-03-30 | Heart valve E velocity/Annulus E wave by US | 16 | {ratio} | <=14 | High | S |
| 1905-06-29 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 720 | pg/mL | <=125 pg/mL | High | S |
| 1905-06-29 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1905-06-29 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1905-06-29 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1905-06-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 61 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1905-06-29 | Glucose [Mass/volume] in Serum or Plasma | 95 | mg/dL | 70-99 mg/dL | Normal | S |
| 1905-06-29 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1905-06-29 | Overall summary score [KCCQ-12] | 70 | {score} | S | ||
| 1905-06-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1905-09-28 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1905-09-28 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1905-09-28 | Creatinine [Mass/volume] in Serum or Plasma | 0.9 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1905-09-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1905-09-28 | Glucose [Mass/volume] in Serum or Plasma | 93 | mg/dL | 70-99 mg/dL | Normal | S |
| 1905-09-28 | Overall summary score [KCCQ-12] | 76 | {score} | S | ||
| 1905-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1905-10-19 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 1905-10-19 | Total score [AUDIT-C] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1905-03-16 | Body height | 165 | cm | S |
| 1905-03-16 | Body weight | 58.5 | kg | S |
| 1905-03-16 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 1905-03-16 | Systolic blood pressure | 158 | mm[Hg] | S |
| 1905-03-16 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1905-03-16 | Heart rate | 84 | /min | S |
| 1905-03-16 | Respiratory rate | 20 | /min | S |
| 1905-03-16 | Body temperature | 36.7 | Cel | S |
| 1905-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1905-03-30 | Body height | 165 | cm | S |
| 1905-03-30 | Body weight | 56.8 | kg | S |
| 1905-03-30 | Body mass index (BMI) [Ratio] | 20.9 | kg/m2 | S |
| 1905-03-30 | Systolic blood pressure | 146 | mm[Hg] | S |
| 1905-03-30 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1905-03-30 | Heart rate | 78 | /min | S |
| 1905-03-30 | Respiratory rate | 18 | /min | S |
| 1905-03-30 | Body temperature | 36.6 | Cel | S |
| 1905-03-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 1905-06-29 | Body height | 165 | cm | S |
| 1905-06-29 | Body weight | 56.2 | kg | S |
| 1905-06-29 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 1905-06-29 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1905-06-29 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1905-06-29 | Heart rate | 72 | /min | S |
| 1905-06-29 | Respiratory rate | 16 | /min | S |
| 1905-06-29 | Body temperature | 36.7 | Cel | S |
| 1905-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1905-09-28 | Body height | 165 | cm | S |
| 1905-09-28 | Body weight | 56 | kg | S |
| 1905-09-28 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 1905-09-28 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1905-09-28 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1905-09-28 | Heart rate | 70 | /min | S |
| 1905-09-28 | Respiratory rate | 16 | /min | S |
| 1905-09-28 | Body temperature | 36.6 | Cel | S |
| 1905-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1905-08-17 | Body height | 165 | cm | S |
| 1905-08-17 | Body weight | 56.3 | kg | S |
| 1905-08-17 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 1905-08-17 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1905-08-17 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1905-08-17 | Heart rate | 88 | /min | S |
| 1905-08-17 | Respiratory rate | 18 | /min | S |
| 1905-08-17 | Body temperature | 37.4 | Cel | S |
| 1905-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1905-10-19 | Body height | 165 | cm | S |
| 1905-10-19 | Body weight | 56.1 | kg | S |
| 1905-10-19 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 1905-10-19 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1905-10-19 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1905-10-19 | Heart rate | 68 | /min | S |
| 1905-10-19 | Respiratory rate | 16 | /min | S |
| 1905-10-19 | Body temperature | 36.6 | Cel | S |
| 1905-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1905-03-16 | Primary care visit for breathlessness on exertion and ankle swelling | finished | S |
| 1905-03-30 | Two-week heart failure medication safety check, echocardiogram, and cardiology consultation | finished | S |
| 1905-06-29 | Three-month heart failure and blood pressure review | finished | S |
| 1905-09-28 | Six-month heart failure review | finished | S |
| 1905-08-17 | Same-day sick visit for a head cold and cough | finished | S |
| 1905-10-19 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Treat congestion with furosemide and start empagliflozin for HFpEF; move to as-needed furosemide guided by daily weights once euvolemic | completed | GL-HF-2022, GL-HFPEF-2023 | S |
| Add low-dose spironolactone for HFpEF with blood pressure above target once potassium and kidney function are stable | completed | GL-HF-2022, GL-HFPEF-2023 | S |
| Cardiology referral to confirm the diagnosis, review the echocardiogram, and look for specific causes such as amyloidosis or valve disease | completed | GL-HF-2022, GL-HFPEF-2023 | S |
| Check a basic metabolic panel and magnesium one to two weeks after starting or changing diuretic, SGLT2 inhibitor, or mineralocorticoid antagonist therapy, then every three to six months; KCCQ-12 every three to six months | completed | GL-CMID-2026, GL-HF-2022 | S |
| Daily weights, sodium moderation, a written travel plan for weight gain, and continued daily walking; refer to cardiac rehabilitation if exercise tolerance plateaus | completed | GL-HF-2022, GL-CMID-2026 | S |
| Pneumococcal and RSV vaccination and a yearly high-dose influenza vaccine to lower the risk of respiratory infection in heart failure | completed | GL-HF-2022, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Reach euvolemia with no ankle edema and a stable dry weight within three months | 1905-06-29 | completed | Dry weight 56 kg; furosemide changed to as-needed use | S |
| Improve the KCCQ-12 overall summary score by at least 15 points by the three-month review | 1905-06-29 | completed | KCCQ-12 rose from 52 to 70 | S |
| Lower blood pressure below 130/80 by the six-month review without orthostatic symptoms | 1905-09-28 | completed | Blood pressure 126/72; no dizziness on standing | S |
| Resume a full speaking and travel schedule by the six-month review | 1905-09-28 | completed | Back to lecturing twice a month with a travel weight plan | S |